CompoAtlas

Bradosol Honey & Eucalyptus

Natural health product licensed in Canada

Licence holder
Columbia Laboratories Canada Inc.
NPN or DIN-HM
80053021
Status
Active licence
Licence date
12 August 2014
Revision date
Not provided
Form
Pastille
Route of administration
Buccale
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Zinc

Source : Glycine de gluconate de zinc

13.3 mg
Ulmus rubra

Source : Stem bark - inner

210 mg
Huile essentielle d'eucalyptus

Source : Arbre à huile d'eucalyptus - feuille

0.575 mg

Non-medicinal ingredients

D-Mannitol, xylitol, Crospovidone, Stéarate de magnésium, Cellulose microcristalline, Hydroxypropylméthylcellulose, Dioxyde de silicium, miel

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Pastilleminimum: 1 Tous les jours ; maximum: 6 Tous les jours
Adultes et adolescentsminimum: 12 years1 Pastilleminimum: 1 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

For temporary relief of sore throat. For the protection of irritated area in throat. For the temporary relief of pain of sore throat. for the temporary relief of coughs. Helps reduce the duration of cold symptoms. Helps reduce the duration of the common cold. With vitamin C an antioxidant for the maintenance of good health. Helps ease/relieve nasal congestion, makes nasal passages feel clearer. Zinc to help maintain immune function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80053021

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line